Iridium Medical Technology Company (IMTC) is an innovative neuron-electronic interface company, and the first to develop high acuity spherical bionic retina, a class III medical device. IMTC develops a proprietary contact lens-shaped 4,000 pixels retinal prosthesis to remedy retinal blindness caused by Retinitis Pigmentosa (RP) and Age-related Macular Degeneration (AMD). IMTC enables patients to recognize faces and objects, read big-print books (font size > 14 pt.), and navigate easily through life by using its 4,000-pixel device